Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI

January 7, 2015 updated by: Dartmouth-Hitchcock Medical Center

The goal of this project, which has not changed, is to evaluate the statewide implementation of a two-component intervention (health promotion plus academic detailing) with respect to consumer outcomes and changes in provider prescribing. The intervention, called In SHAPE, is delivered to people with serious mental illness (SMI) by two community mental health clinics (CMHCs). These CMHCs are compared to two CMHCs delivering usual-care to individuals with SMI. The specific aims of this study are:

  1. Evaluate person-level and provider-level outcomes including: (a) consumer health behaviors, health indicators, mental health indicators, and acute health service utilization, (b) provider prescribing practices and program fidelity, and (c) program costs.
  2. Evaluate system-level outcomes including: (a) consumer health behaviors and health indicators, (b) provider prescribing and program fidelity, and (c) acute services use.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Individuals with SMI die 10-25 years earlier than the general population and have disproportionately greater rates of medical comorbidity and disability associated with high rates of obesity, sedentary lifestyle, metabolic syndrome, and poor dietary habits. Despite greater costs and adverse outcomes associated with the combination of mental illness and poor physical health, little attention has been paid to the development of health promotion interventions designed to address the needs of the high-risk group of people with SMI. This natural experiment presents an unprecedented opportunity to evaluate the public health impact of a statewide health-promotion program for persons with SMI, a potential model for reducing early mortality among persons with SMI served by state mental-health systems nationwide.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Hampshire
      • Lebanon, New Hampshire, United States, 03766
        • West Central Behavioral Health
      • Manchester, New Hampshire, United States, 03103
        • Mental Health Center of Greater Manchester
      • Nashua, New Hampshire, United States, 03060
        • Greater Nashua Mental Health Center at Community Council
      • Salem, New Hampshire, United States, 03079
        • Center for Life Management

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 21 or older
  • Serious mental illness defined by (a) an axis I diagnosis of major depression, bipolar disorder, schizoaffective disorder, or schizophrenia, (b) moderate impairment across multiple areas of psychological functioning, or (c) Global Assessment of Functioning (GAF) score less than 61
  • Able to provide voluntary informed consent for participation in the study by the participant or by the participant's legally designated guardian or conservator
  • Poor fitness as indicated by BMI > 25 or failure to adhere to the US Department of Health and Human Services Physical Activity Guidelines for Americans, i.e., at least 2.5 hr/week of moderate or 75 min/week of vigorous activity in more than one session
  • Medical clearance for participation in an exercise and dietary modification program by a physician, physician assistant, or nurse practitioner
  • An expressed willingness to participate in a diet and exercise program
  • Currently taking an atypical antipsychotic medication
  • Able to walk a city block
  • Responsible for choice of foods and how they are prepared

Exclusion Criteria:

  • Currently residing in a nursing home or group home
  • Terminal physical illness expected to result in the death of the study subject within one year
  • Primary diagnosis of dementia, co-morbid diagnosis of dementia, or significant cognitive impairment as indicated by a Mini-Mental State Examination (MMSE) score < 24
  • Inability to speak and understand English
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: In SHAPE
In SHAPE is a health promotion intervention consisting of a fitness club membership and a health promotion coach with basic certification as a fitness trainer, instruction on principles of healthy eating and nutrition, and training in tailoring individual wellness plans to the needs of persons with serious mental illness.
In SHAPE is a health promotion intervention consisting of a fitness club membership and a health promotion coach with basic certification as a fitness trainer, instruction on principles of healthy eating and nutrition, and training in tailoring individual wellness plans to the needs of persons with serious mental illness.
No Intervention: Usual-Care Control
Usual-care consumers agreed to delay participation in In SHAPE for 12 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in exercise capacity
Time Frame: baseline, 6-, 12-, and 24-months
Change in exercise capacity measured by the 6-minute walk test.
baseline, 6-, 12-, and 24-months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported physical activity
Time Frame: baseline, 6-, 12-, and 24-months
Change in self-reported physical activity measured with International Physical Activity Questionnaire (IPAQ)
baseline, 6-, 12-, and 24-months
Change in dietary behaviors
Time Frame: baseline, 6-, 12-, and 24-months
Change in dietary behaviors measured with the Block Food Frequency Questionnaire (FFQ)21 and the Questionnaire on Eating and Weight Patterns (QEWP).
baseline, 6-, 12-, and 24-months
Change in stage of change
Time Frame: baseline, 6-, 12-, and 24-months
Change in stage of change measured with the Weight Loss Behavior-Stage of Change Scale (WLB-SOC) 23 to assess stage of change for engaging in healthy eating and exercise behaviors.
baseline, 6-, 12-, and 24-months
Change in eating behavior
Time Frame: baseline, 6-, 12-, and 24-months
Change in eating behavior measured with the Dutch Eating Behavior Questionnaire which includes 13 questions assessing emotional eating and 10 questions related to external eating behaviors
baseline, 6-, 12-, and 24-months
Change in physical measurement
Time Frame: baseline, 6-, 12-, and 24-months
Including height, weight, pulse, CO2 level, lung capacity from spirometer, variables from impedance measure such as percentage of body fat and percentage of lean muscle mass, cholesterol and triglyceride levels from finger stick (cholesterol data for data points that have already passed will be collected from participants' clinic and hospital records), waist circumference: BMI derived from height and weight.
baseline, 6-, 12-, and 24-months
Change in smoking and substance use
Time Frame: baseline, 6-, 12-, and 24-months
Change in smoking and substance use measured by questions developed for R01DA021245, "Smoking Cessation and Smoking Relapse Prevention in Patients with Schizophrenia," and questions from the "Quit Smoking Decision Aid"( developed by Ferron and Brunette, CPHS # 180) to ascertain smoking frequency, quantity, and cessation attempts
baseline, 6-, 12-, and 24-months
Change in psychological functioning (depression, negative symptoms, and self-efficacy).
Time Frame: baseline, 6-, 12-, and 24-months
Change in psychological functioning measured by the Center for Epidemiologic Studies Depression Scale,Scale to Assess Negative Symptoms,16 and the Self-Rated Abilities for Health Practices Scale will be used to assess these constructs.
baseline, 6-, 12-, and 24-months
Change in social functioning
Time Frame: baseline, 6-, 12-, and 24-months
Change in social functioning measured by the Social Network Questionnaire and Lehman Social Contact Scale.
baseline, 6-, 12-, and 24-months
Change in family contact
Time Frame: baseline, 6-, 12-, and 24-months
Change in family contact measured by the Revised Family Contact Questionnaire.
baseline, 6-, 12-, and 24-months
Change in social support and eating habits
Time Frame: baseline, 6-, 12-, and 24-months
Change in the impact of social support on eating habits measured by the Social Support and Eating Habits Survey
baseline, 6-, 12-, and 24-months
Change in social support and exercise
Time Frame: baseline, 6-, 12-, and 24-months
Change in the impact of social support on exercise behaviors measured by the Social Support and Exercise Survey
baseline, 6-, 12-, and 24-months
Change in comorbid medical illness
Time Frame: baseline, 6-, 12-, and 24-months
Change in comorbid medical illness measured using a medical problems list.
baseline, 6-, 12-, and 24-months
Change in medications
Time Frame: baseline, 6-, 12-, and 24-months
Change in medications measured by gathering information from participants about type, dose, and frequency of all prescribed medications.
baseline, 6-, 12-, and 24-months
Change in service use
Time Frame: baseline, 6-, 12-, and 24-months
Measured change in service use based on a measured designed for the In SHAPE studies to collect self-reported use of emergency services and hospitalizations.
baseline, 6-, 12-, and 24-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephen J Bartels, MD, MS, Dartmouth-Hitchcock Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (Actual)

May 1, 2013

Study Completion (Actual)

May 1, 2013

Study Registration Dates

First Submitted

January 6, 2015

First Submitted That Met QC Criteria

January 7, 2015

First Posted (Estimate)

January 8, 2015

Study Record Updates

Last Update Posted (Estimate)

January 8, 2015

Last Update Submitted That Met QC Criteria

January 7, 2015

Last Verified

January 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on In SHAPE

3
Subscribe